Noelle Marie Cocoros, D.Sc.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Influenza, Human | 13 | 2022 | 1479 | 3.070 |
Why?
|
Product Surveillance, Postmarketing | 4 | 2021 | 430 | 1.340 |
Why?
|
United States Food and Drug Administration | 12 | 2022 | 1584 | 1.340 |
Why?
|
Influenza A Virus, H1N1 Subtype | 4 | 2021 | 459 | 0.850 |
Why?
|
Drug Utilization | 2 | 2019 | 1183 | 0.840 |
Why?
|
Pneumonia, Ventilator-Associated | 4 | 2021 | 274 | 0.840 |
Why?
|
Public Health Informatics | 2 | 2020 | 110 | 0.820 |
Why?
|
Research Design | 4 | 2023 | 5987 | 0.820 |
Why?
|
Drug Prescriptions | 5 | 2023 | 1637 | 0.770 |
Why?
|
Lyme Disease | 2 | 2023 | 621 | 0.730 |
Why?
|
Respiration, Artificial | 5 | 2021 | 2569 | 0.720 |
Why?
|
Drug Tolerance | 2 | 2018 | 376 | 0.710 |
Why?
|
Electronic Health Records | 12 | 2024 | 4468 | 0.690 |
Why?
|
Antiviral Agents | 6 | 2022 | 2987 | 0.680 |
Why?
|
International Classification of Diseases | 2 | 2022 | 867 | 0.670 |
Why?
|
Prenatal Exposure Delayed Effects | 3 | 2018 | 2408 | 0.640 |
Why?
|
Ventilators, Mechanical | 2 | 2021 | 292 | 0.630 |
Why?
|
Drug Utilization Review | 1 | 2018 | 245 | 0.600 |
Why?
|
Algorithms | 7 | 2023 | 13881 | 0.590 |
Why?
|
Drug Labeling | 1 | 2019 | 233 | 0.590 |
Why?
|
Mycophenolic Acid | 1 | 2019 | 343 | 0.570 |
Why?
|
Ventilator-Induced Lung Injury | 2 | 2021 | 122 | 0.570 |
Why?
|
Oseltamivir | 3 | 2022 | 75 | 0.550 |
Why?
|
Fentanyl | 1 | 2018 | 410 | 0.540 |
Why?
|
Respiratory Tract Infections | 1 | 2023 | 961 | 0.540 |
Why?
|
Information Storage and Retrieval | 2 | 2020 | 824 | 0.530 |
Why?
|
Drug Monitoring | 2 | 2019 | 956 | 0.530 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2019 | 469 | 0.520 |
Why?
|
Denmark | 4 | 2021 | 738 | 0.500 |
Why?
|
Antitubercular Agents | 1 | 2022 | 1320 | 0.490 |
Why?
|
Massachusetts | 15 | 2023 | 8663 | 0.490 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2019 | 789 | 0.490 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1381 | 0.460 |
Why?
|
Insurance, Health | 3 | 2020 | 2494 | 0.450 |
Why?
|
Anticoagulants | 5 | 2022 | 4599 | 0.450 |
Why?
|
Medication Errors | 1 | 2019 | 798 | 0.450 |
Why?
|
Venous Thrombosis | 1 | 2022 | 1239 | 0.440 |
Why?
|
Sentinel Surveillance | 5 | 2023 | 281 | 0.430 |
Why?
|
Clinical Protocols | 1 | 2018 | 1462 | 0.430 |
Why?
|
United States | 30 | 2024 | 69872 | 0.420 |
Why?
|
Chlamydia Infections | 3 | 2021 | 365 | 0.420 |
Why?
|
Prisons | 1 | 2014 | 161 | 0.410 |
Why?
|
Anti-Bacterial Agents | 5 | 2022 | 7181 | 0.390 |
Why?
|
Outpatients | 1 | 2018 | 1486 | 0.370 |
Why?
|
Hospitalization | 6 | 2022 | 10262 | 0.370 |
Why?
|
Intensive Care Units | 3 | 2021 | 3679 | 0.370 |
Why?
|
Atrial Fibrillation | 5 | 2022 | 5034 | 0.360 |
Why?
|
Pneumonia | 1 | 2022 | 2133 | 0.360 |
Why?
|
Electronics | 2 | 2022 | 322 | 0.360 |
Why?
|
Tuberculosis | 1 | 2022 | 1912 | 0.360 |
Why?
|
Hepatitis C | 3 | 2015 | 1591 | 0.350 |
Why?
|
Pulmonary Embolism | 1 | 2022 | 2376 | 0.350 |
Why?
|
Humans | 64 | 2024 | 744343 | 0.320 |
Why?
|
HIV Infections | 5 | 2024 | 16718 | 0.310 |
Why?
|
Medicare | 2 | 2023 | 6566 | 0.310 |
Why?
|
Parkinson Disease | 1 | 2021 | 2775 | 0.310 |
Why?
|
Myocardial Infarction | 2 | 2022 | 11727 | 0.300 |
Why?
|
Antidepressive Agents | 1 | 2019 | 2838 | 0.300 |
Why?
|
Databases, Factual | 6 | 2022 | 7729 | 0.290 |
Why?
|
Pandemics | 5 | 2024 | 8388 | 0.290 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 3068 | 0.280 |
Why?
|
Gonorrhea | 2 | 2021 | 335 | 0.280 |
Why?
|
Infant, Newborn | 9 | 2019 | 25625 | 0.270 |
Why?
|
Thromboembolism | 2 | 2022 | 986 | 0.270 |
Why?
|
Analgesics, Opioid | 2 | 2018 | 3674 | 0.260 |
Why?
|
Adolescent | 20 | 2022 | 85781 | 0.260 |
Why?
|
Inappropriate Prescribing | 3 | 2024 | 202 | 0.250 |
Why?
|
Infant | 12 | 2020 | 35136 | 0.250 |
Why?
|
Child, Preschool | 11 | 2019 | 41006 | 0.240 |
Why?
|
Military Personnel | 1 | 2013 | 1133 | 0.240 |
Why?
|
Population Surveillance | 6 | 2023 | 2616 | 0.230 |
Why?
|
Dementia | 1 | 2018 | 2518 | 0.230 |
Why?
|
Disease Notification | 2 | 2022 | 97 | 0.230 |
Why?
|
Pain | 1 | 2018 | 4986 | 0.230 |
Why?
|
Stroke | 4 | 2022 | 9981 | 0.210 |
Why?
|
Aged | 19 | 2024 | 163280 | 0.210 |
Why?
|
Health Services Misuse | 2 | 2020 | 243 | 0.200 |
Why?
|
Child | 14 | 2023 | 77709 | 0.200 |
Why?
|
Adult | 23 | 2024 | 214055 | 0.200 |
Why?
|
Young Adult | 15 | 2022 | 56430 | 0.190 |
Why?
|
Isoniazid | 1 | 2022 | 274 | 0.190 |
Why?
|
Communicable Disease Control | 2 | 2021 | 857 | 0.190 |
Why?
|
Rifampin | 1 | 2022 | 315 | 0.190 |
Why?
|
Obesity | 2 | 2013 | 12745 | 0.190 |
Why?
|
Male | 28 | 2022 | 350118 | 0.190 |
Why?
|
Cross Infection | 2 | 2021 | 1416 | 0.180 |
Why?
|
Dopamine Antagonists | 1 | 2021 | 296 | 0.180 |
Why?
|
Female | 29 | 2022 | 380194 | 0.180 |
Why?
|
Antiparkinson Agents | 1 | 2021 | 184 | 0.180 |
Why?
|
Sample Size | 1 | 2023 | 845 | 0.180 |
Why?
|
Middle Aged | 19 | 2022 | 213383 | 0.180 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2023 | 780 | 0.170 |
Why?
|
Zanamivir | 1 | 2018 | 21 | 0.170 |
Why?
|
Transdermal Patch | 1 | 2018 | 51 | 0.160 |
Why?
|
Seizures, Febrile | 1 | 2020 | 111 | 0.160 |
Why?
|
Quality Improvement | 4 | 2022 | 3749 | 0.160 |
Why?
|
Syphilis | 1 | 2021 | 227 | 0.160 |
Why?
|
Retrospective Studies | 9 | 2022 | 77449 | 0.160 |
Why?
|
Incidence | 4 | 2022 | 20947 | 0.160 |
Why?
|
Delayed-Action Preparations | 2 | 2018 | 968 | 0.160 |
Why?
|
Off-Label Use | 1 | 2019 | 169 | 0.160 |
Why?
|
CD4 Lymphocyte Count | 1 | 2024 | 2559 | 0.150 |
Why?
|
Aged, 80 and over | 8 | 2022 | 57776 | 0.150 |
Why?
|
Alzheimer Disease | 3 | 2024 | 8037 | 0.140 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2017 | 199 | 0.140 |
Why?
|
Administration, Cutaneous | 1 | 2018 | 711 | 0.140 |
Why?
|
Patient Dropouts | 1 | 2019 | 421 | 0.140 |
Why?
|
Pharmaceutical Preparations | 2 | 2022 | 1071 | 0.140 |
Why?
|
Pneumococcal Vaccines | 1 | 2020 | 391 | 0.140 |
Why?
|
Health Plan Implementation | 1 | 2019 | 352 | 0.140 |
Why?
|
Case-Control Studies | 3 | 2021 | 21746 | 0.140 |
Why?
|
Prescriptions | 1 | 2018 | 387 | 0.130 |
Why?
|
Anti-Asthmatic Agents | 1 | 2020 | 536 | 0.130 |
Why?
|
Quinolines | 1 | 2020 | 732 | 0.130 |
Why?
|
Contraception | 1 | 2019 | 359 | 0.130 |
Why?
|
Whooping Cough | 1 | 2015 | 82 | 0.130 |
Why?
|
Sexually Transmitted Diseases | 1 | 2021 | 624 | 0.130 |
Why?
|
Hepatitis C Antibodies | 1 | 2014 | 145 | 0.120 |
Why?
|
Hospital Mortality | 3 | 2018 | 5317 | 0.120 |
Why?
|
Infection Control | 1 | 2021 | 966 | 0.120 |
Why?
|
Drug Interactions | 1 | 2019 | 1460 | 0.120 |
Why?
|
Risk Factors | 7 | 2022 | 72290 | 0.120 |
Why?
|
Pulmonary Edema | 1 | 2016 | 414 | 0.120 |
Why?
|
Uterus | 1 | 2018 | 711 | 0.120 |
Why?
|
Cost of Illness | 1 | 2023 | 1859 | 0.120 |
Why?
|
Inpatients | 2 | 2024 | 2518 | 0.120 |
Why?
|
Local Government | 1 | 2014 | 80 | 0.110 |
Why?
|
Oxygen | 2 | 2024 | 4189 | 0.110 |
Why?
|
Patient Care | 1 | 2019 | 640 | 0.110 |
Why?
|
Respiratory Insufficiency | 1 | 2021 | 1199 | 0.110 |
Why?
|
Odds Ratio | 2 | 2017 | 9849 | 0.110 |
Why?
|
AIDS Serodiagnosis | 1 | 2014 | 184 | 0.110 |
Why?
|
Risk Assessment | 4 | 2022 | 23338 | 0.110 |
Why?
|
Delivery of Health Care | 2 | 2022 | 5319 | 0.110 |
Why?
|
Influenza Vaccines | 1 | 2020 | 738 | 0.110 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2014 | 323 | 0.100 |
Why?
|
Case Management | 1 | 2014 | 286 | 0.100 |
Why?
|
Health Policy | 2 | 2022 | 2661 | 0.100 |
Why?
|
Cohort Studies | 5 | 2021 | 40561 | 0.100 |
Why?
|
Hemorrhage | 2 | 2022 | 3461 | 0.100 |
Why?
|
Weight Gain | 1 | 2022 | 2292 | 0.100 |
Why?
|
Continuity of Patient Care | 1 | 2019 | 1049 | 0.100 |
Why?
|
Health Services Research | 1 | 2019 | 1836 | 0.100 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2019 | 1130 | 0.100 |
Why?
|
Pregnancy | 5 | 2019 | 29144 | 0.100 |
Why?
|
Mumps virus | 1 | 2010 | 24 | 0.100 |
Why?
|
Hospitals | 3 | 2023 | 3952 | 0.100 |
Why?
|
Intensive Care Units, Pediatric | 1 | 2017 | 981 | 0.100 |
Why?
|
Prisoners | 1 | 2014 | 297 | 0.090 |
Why?
|
Enzyme-Linked Immunospot Assay | 1 | 2010 | 130 | 0.090 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2010 | 66 | 0.090 |
Why?
|
Warfarin | 1 | 2019 | 1496 | 0.090 |
Why?
|
Mumps | 1 | 2010 | 64 | 0.090 |
Why?
|
Risk | 1 | 2022 | 9687 | 0.090 |
Why?
|
History, 20th Century | 1 | 2018 | 2740 | 0.090 |
Why?
|
Polypharmacy | 2 | 2024 | 294 | 0.090 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2013 | 2026 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2019 | 5078 | 0.090 |
Why?
|
Body Mass Index | 3 | 2022 | 12720 | 0.080 |
Why?
|
Thrombosis | 1 | 2022 | 2968 | 0.080 |
Why?
|
Patient Compliance | 1 | 2019 | 2684 | 0.080 |
Why?
|
Ambulatory Care | 1 | 2019 | 2708 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 9959 | 0.080 |
Why?
|
Medication Adherence | 1 | 2019 | 2063 | 0.070 |
Why?
|
Confidence Intervals | 1 | 2013 | 2971 | 0.070 |
Why?
|
Chronic Disease | 2 | 2023 | 9146 | 0.070 |
Why?
|
Mass Screening | 2 | 2020 | 5255 | 0.070 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2020 | 2208 | 0.070 |
Why?
|
Acute Coronary Syndrome | 1 | 2019 | 2337 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6442 | 0.070 |
Why?
|
Communicable Diseases | 1 | 2014 | 880 | 0.060 |
Why?
|
Logistic Models | 2 | 2017 | 13408 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8324 | 0.060 |
Why?
|
Prevalence | 4 | 2023 | 15226 | 0.060 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.060 |
Why?
|
Length of Stay | 1 | 2016 | 6309 | 0.060 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2019 | 4644 | 0.050 |
Why?
|
Asthma | 1 | 2020 | 6011 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2009 | 1772 | 0.040 |
Why?
|
Comorbidity | 3 | 2022 | 10388 | 0.040 |
Why?
|
Sulfides | 1 | 2020 | 165 | 0.040 |
Why?
|
Public Health | 2 | 2023 | 2603 | 0.040 |
Why?
|
Antibodies, Viral | 1 | 2010 | 3176 | 0.040 |
Why?
|
Pharmacy | 1 | 2021 | 91 | 0.040 |
Why?
|
Acetates | 1 | 2020 | 311 | 0.040 |
Why?
|
Cyclopropanes | 1 | 2020 | 416 | 0.040 |
Why?
|
Australia | 1 | 2022 | 1170 | 0.040 |
Why?
|
Vaccines, Conjugate | 1 | 2020 | 333 | 0.040 |
Why?
|
Diuretics | 1 | 2021 | 592 | 0.040 |
Why?
|
Survival Analysis | 1 | 2011 | 10252 | 0.040 |
Why?
|
Calcium Channel Blockers | 1 | 2021 | 690 | 0.040 |
Why?
|
Ethics, Research | 1 | 2019 | 191 | 0.040 |
Why?
|
Registries | 1 | 2013 | 8089 | 0.040 |
Why?
|
B-Lymphocytes | 1 | 2010 | 4665 | 0.040 |
Why?
|
Urinalysis | 1 | 2017 | 369 | 0.030 |
Why?
|
Sexual Partners | 1 | 2019 | 730 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2022 | 3870 | 0.030 |
Why?
|
Homosexuality, Male | 1 | 2020 | 1240 | 0.030 |
Why?
|
HIV | 1 | 2020 | 1604 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2021 | 2309 | 0.030 |
Why?
|
Administration, Oral | 1 | 2020 | 3913 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2020 | 1411 | 0.030 |
Why?
|
Caregivers | 1 | 2024 | 2094 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25043 | 0.030 |
Why?
|
Rubella virus | 1 | 2010 | 11 | 0.020 |
Why?
|
Measles virus | 1 | 2010 | 68 | 0.020 |
Why?
|
Antibody-Producing Cells | 1 | 2010 | 143 | 0.020 |
Why?
|
Rubella | 1 | 2010 | 48 | 0.020 |
Why?
|
Research | 1 | 2019 | 1999 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2020 | 6489 | 0.020 |
Why?
|
Measles | 1 | 2010 | 168 | 0.020 |
Why?
|
Geography | 1 | 2011 | 669 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3019 | 0.020 |
Why?
|
Health Behavior | 1 | 2017 | 2636 | 0.020 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3022 | 0.020 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.020 |
Why?
|
Acute Disease | 1 | 2015 | 7149 | 0.020 |
Why?
|
Age Distribution | 1 | 2011 | 2902 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 3923 | 0.020 |
Why?
|
Immunologic Memory | 1 | 2010 | 1348 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3064 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2017 | 15076 | 0.010 |
Why?
|
Vaccination | 1 | 2010 | 3278 | 0.010 |
Why?
|
Prospective Studies | 1 | 2022 | 53288 | 0.010 |
Why?
|
Time Factors | 1 | 2019 | 40075 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2019 | 63114 | 0.010 |
Why?
|